Extensive research in mouse models has provided extensive knowledge about the potent and efficient effects of GLP-1 analogues in T2DM, obesity, and their comorbidities which have been described in recent excellent reviews [21,37] and meta-analyses [59]. Here, GLP1R is linked to obesity disorder.